Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents

Details for Australian Patent Application No. 2010311437 (hide)

Owner General Electric Company

Inventors Bales, Brian C.; Hay, Bruce Alan; Kandapallil, Binil Itty Ipe

Agent Davies Collison Cave

Pub. Number AU-A-2010311437

PCT Pub. Number WO2011/051422

Priority 12/609,799 30.10.09 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

A61K 49/18 (2006.01) Preparations for testing

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/051422 Priority application(s): WO2011/051422

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010311439-Biodegradable implantable medical devices formed from super - pure magnesium-based material

2010311421-Sterilization of biodegradable hydrogels